Substance Abuse Treatment Market Research Report: By Abuse Type (Alcohol Dependence, Tobacco & Drug Abuse, Treatment (Alcohol Addiction (Disulfiram, Acamprosate, & others), Nicotine Addiction & Drug Abuse))), End User, - Forecast Till 2030

Substance Abuse Treatment Market Overview:

The Substance Abuse Treatment Market is expected to reach USD 5.80 Billion by 2030 at 10.90% CAGR during the forecast period 2022-2030.

The factors driving the market growth include the rising drug awareness campaigns and prevention programs and the increase in the number of addictions among the population. The surge in drug awareness campaigns and associated prevention programs is one of the primary factors linked to the market's growth. This includes the rising patient awareness, a higher treatment-seeking rate with the increased government intervention, and the encouragement to curb substance abuse in numerous countries.

The campaigns provide information about the prevalence and the dangers of fentanyl, the risks and the consequences of the mixing of drugs, the life-saving power of naloxone and the importance of reducing the stigma around the drug use to support the treatment and recovery. Such campaigns and initiatives are increasing awareness regarding substance abuse treatment among the addicted population, thereby contributing to the market growth. However, the reluctance of the individuals to access treatment modalities, the discontinuation of the behavioral therapies and the poor treatment compliance in some countries decrease the growth of the market.

Segmentation

The global substance abuse treatment market is segmented based on abuse type, treatment type, end user, and region.

The global market for substance abuse treatment, by abuse type is segmented into alcohol dependence, tobacco/nicotine addiction, and drug abuse. The drug abuse segment is anticipated to hold the largest market share owing to the increasing addiction of opioid.

The market, by treatment type, is segmented into alcohol addiction treatment, tobacco/nicotine addiction treatment, and drug abuse treatment. The alcohol addiction treatment segment is further classified as disulfiram, acamprosate, and naltrexone. The tobacco/nicotine addiction treatment segment is further classified as nicotine replacement treatment, and non-nicotine medication. The nicotine replacement treatment segment includes nicotine patch, nicotine gum, nicotine lozenge, nicotine spray, and nicotine inhaler. The non-nicotine medication segment includes bupropion, and varenicline. The drug abuse treatment segment is further classified as methadone, buprenorphine, and naltrexone.

Based on end user, the market is segmented into outpatient treatment centres, residential treatment centres, and inpatient treatment centres.

In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.

The substance abuse treatment market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European substance abuse treatment market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The substance abuse treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The substance abuse treatment market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Substance Abuse Treatment market Share (%), by Region, 2017

Sources: MRFR Analysis

The Americas dominated the global market for substance abuse treatment owing to presence of major market players and rising awareness about substance abuse treatment within the region. In recent years, various private and government organizations have launched campaigns and seminar to spread awareness about substance abuse. For instance, in February 2017, the Ad Council and Viacom have launched the LISTEN campaign and a new PSA to address America’s substance abuse crisis.

In 2017, it was estimated that Europe stood second in the global substance abuse treatment market. This can be attributed to the rising research and development investments.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as increasing incidences of tobacco addiction and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region. According to the information published in the Frontiers in Psychiatry journal, China is facing an immense public health challenge from tobacco smoking. It is estimated that number of deaths, due to cigarette smoking, will reach 2 million by 2030 and 3 million by 2050.

On the other hand, the Middle East and Africa held least share in the global substance abuse treatment market due to the low per capita income, especially within the African region.

Key players

Some of the key players in the global substance abuse treatment market are Pfizer Inc., Alkermes Plc, GlaxoSmithKline Plc., Purdue Pharma LP, Allergan, Mylan Laboratories, Reckitt Benckiser Pharmaceuticals, Teva Pharmaceuticals, Forest Laboratories, Inc., Accord Healthcare, Amphastar Pharmaceuticals, Apotex, BioCorRx, Cipla, Glenmark, INSYS Therapeutics, LFB Group, Lupin, Opiant Technologies, Sanofi Aventis, Sanquin, Sterinova, Sun Pharmaceuticals, and others.

Research Methodology

Market Research Future research is conducted by industry experts who offer insights into industry structure, market segmentation, assessment, Competitive Landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analysing historical trends and current market positions. Furthermore, the varying trends of segments and categories geographically presented are studied and are estimated based on the primary and secondary research.

• Primary Research

Extensive primary research was conducted to gain a deeper insight of the market and the industry performance. In this particular report we have conducted primary surveys (interviews) with key level executives (VPs, CEOs, Marketing Directors, Business Development Managers, and many more) of major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.

• Secondary Research

Secondary research was mainly used to collect and identify information useful for extensive, technical, market-oriented, and commercial study of the substance abuse treatment. It was also used to obtain key information about major players, market classification, and segmentation according to industry trends, geographical markets, and developments related to the market and perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company web sites, international organization of chemical manufacturers, some paid databases, and many others.Recent Development

July 2021

In July 2021, the same source stated that tobacco kills more than 8 million people each year. More than 7 million of those deaths result from direct tobacco use, while around 1.2 million are the result of non-smokers being exposed to second-hand smoke. However, tobacco use is greater in developing and underdeveloped countries, especially in Pacific and East Asian regions.

December 2021

In December 2021, the NFL Biosciences launched phase 2 or 3 clinical trials to assess the efficiency and safety of its NFL-101 smoking cessation treatment. It is approved by the Human Research Ethics Committee in Australia and by the French National Agency to protect medicines and health products.

Intended Audience

• Pharmaceutical Companies


• Government and Private Laboratories


• Research and Development (R&D) companies


• Medical Research Laboratories


• Market Research and Consulting Service Providers

Market Segmentation and Key Market Players

Substance Abuse Treatment Market, by Abuse Type

• Alcohol Dependence


• Tobacco/Nicotine Addiction


• Drug Abuse


• Others

Substance Abuse Treatment Market, by Treatment Type

• Alcohol Addiction Treatment
  
  
  
  • Disulfiram
  
  
  • Acamprosate
  
  
  • Naltrexone
  
  
  
  


• Tobacco/Nicotine Addiction Treatment
  
  
  
  • Nicotine Replacement Treatment
    
    
    
    • Nicotine Patch
    
    
    • Nicotine Gum
    
    
    • Nicotine Lozenge
    
    
    • Nicotine Spray
    
    
    • Nicotine Inhaler
    
    
    
    
  
  
  • Non-Nicotine Medication
    
    
    
    • Bupropion
    
    
    • Varenicline
    
    
    
    
  
  
  
  


• Drug Abuse Treatment
  
  
  
  • Methadone
  
  
  • Buprenorphine
  
  
  • Naltrexone
  
  
  
  

Substance Abuse Treatment Market, by End User

• Outpatient Treatment Centers


• Residential Treatment Centers


• Inpatient Treatment Centers